Switch to:
More From Other Websites
Jazz Pharmaceuticals to Report 2016 Fourth Quarter and Full Year Financial Results on February 28,... Feb 14 2017
5 Drug Stocks Poised to Beat Earnings Estimates in Q4 Feb 09 2017
Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 2 Clinical Study Evaluating JZP-110... Feb 08 2017
Actinium Pharmaceuticals Is Better Than Celator Feb 07 2017
Jazz Pharmaceuticals Manufacturing Plant Gets Warning Jan 27 2017
Jazz Pharmaceuticals Plc: Leads amongst peers with strong fundamentals Jan 19 2017
Can Jazz Pharmaceuticals Be a Top Choice for Value Investors? Jan 19 2017
Jazz Rebuffs Concerns Of Generic Sleep Drug Amid Patent Litigation Jan 18 2017
Wednesday’s Top Biopharma Winners Jan 18 2017
FDA Approves Generic of Jazz Pharma's Sleep Drug Jan 18 2017
Jazz Begins Phase III Study for Label Expansion of Defitelio Jan 18 2017
JAZZ PHARMACEUTICALS PLC Files SEC form 8-K, Other Events Jan 18 2017
Neurocrine Med Failure, Jazz Pharma Generic Rival OK Sends Both Down Jan 17 2017
FDA approves generic version of Jazz Pharma's sleep disorder drug Jan 17 2017
Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 3 Clinical Trial Evaluating... Jan 17 2017
Jazz Pharmaceuticals Announces Participation in Three Upcoming Investor Conferences Nov 10 2016
Jazz Pharmaceuticals Announces Third Quarter 2016 Financial Results Nov 08 2016
Jazz Pharmaceuticals to Report 2016 Third Quarter Financial Results on November 8, 2016 Oct 25 2016
Jazz Pharmaceuticals Initiates Rolling NDA Submission for Vyxeos (CPX-351) Expects to Complete NDA... Oct 03 2016
Jazz Pharmaceuticals Announces That Patient Enrollment is Complete for the Phase 3 Studies of... Sep 26 2016
Jazz Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference Sep 17 2016
Jazz Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference Sep 07 2016
Jazz Pharmaceuticals Announces Second Quarter 2016 Financial Results Aug 09 2016
Hercules Announces Strong Second Quarter Financial Results with $ ... Aug 04 2016
Jazz Pharmaceuticals and Pfenex Enter into a Worldwide License and Option Agreement Related to... Jul 28 2016
Jazz Pharmaceuticals and Pfenex Enter into a Worldwide License and Option Agreement Related to... Jul 28 2016
Jazz Pharmaceuticals to Report 2016 Second Quarter Financial Results on August 9, 2016 Jul 25 2016
Jazz Pharmaceuticals plc Announces Results of Tender Offer to Purchase All of The Outstanding Shares... Jul 12 2016
Jazz Pharmaceuticals Announces Expiration of HSR Waiting Period for Proposed Celator... Jun 26 2016
Jazz Pharmaceuticals Announces Conference Call and Webcast for JZP-110 Investor Update Jun 14 2016
Jazz Pharmaceuticals Presents New Data from a Human Abuse Liability (HAL) Study for JZP-110, an... Jun 14 2016
Jazz Pharma to buy Celator in $1.5 billion deal May 31 2016
Jazz Pharmaceuticals And Celator Pharmaceuticals Announce Agreement For Jazz Pharmaceuticals To... May 31 2016
Jazz Pharma nears deal to buy Celator for about $1.5 billion - WSJ May 30 2016
Jazz Pharmaceuticals Announces Participation in Two Upcoming Investor Conferences May 18 2016
Jazz Pharmaceuticals Announces First Quarter 2016 Financial Results May 10 2016
Jazz Pharmaceuticals to Report 2016 First Quarter Financial Results on May 10, 2016 Apr 26 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK